3 completed, 1 recruiting. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Ranibizumab Ophthalmic: new trials by email Literature Review of Ranibizumab Ophthalmic trials Research Report on Ranibizumab Ophthalmic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD) Bevacizumab, Ranibizumab Ophthalmic - Wet Age-related Macular Degeneration | Phase 3 | Recruiting | Parc de Salut Mar | 630 | 2022-11-18 | 2025-11-20 |
| VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP Bevacizumab Injection, Ranibizumab Ophthalmic - Retinopathy of Prematurity Both Eyes, Retinal Disease | Phase 4 | Completed | Universidad Autonoma de San Luis Potosà | 16 | 2017-05-23 | 2019-01-09 |
| Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema Ranibizumab Ophthalmic - Diabetic Macular Edema | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 51 | 2014-09-01 | 2019-05-02 | |
| Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration OCT, Multifocal ERG, Microperimetry, Ranibizumab Ophthalmic - Neovascular Age Related Macular Degeneration | Phase 2 / Phase 3 | Completed | Retina Macula Institute | 91 | 2008-10-01 | 2020-09-22 |
Eye Diseases (1) · Premature Birth (1) · Retinal Diseases (1) · Retinopathy of Prematurity (1)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Parc de Salut Mar (1) · Retina Macula Institute (1) · Universidad Autonoma de San Luis Potosà (1)
Mexico (1) · Spain (1) · United States (1)
Cindy Hutnik, MD, PhD (1) · Martha G Rangel, MD (1) · Ron P. Gallemore, MD, PhD (1)
2019 (1)